Ann: First Responder Device Unveiled, page-14

First 14 Last

Share
Profile

Follow
BuffettWarren

1,715 Posts.

195

23/07/24

15:29

Post #: 74876149
Share

Originally posted by vintage: ↑

"Would like to think that both products would be up and running in many medical facilities within 18 months"

Would be nice - but I can't see that happening.

The meeting with FDA to finalise validation study protocols and endpoints is not until October. There may be issues raised and further clarifications required. But lets assume best case and all is good to go. So validation trial commences Nov-Dec. You would have to think the trial would be at least 6 months - maybe longer if need to recruit more than a few bleed patients. Lets assume 6 months and then 3 months to process data, then a few more months to finalise submission to FDA. That takes it to Nov-Dec 2025. FDA minimum timeline for de Novo submissions is 150 review days or 30 weeks but average is over a year, with only 1% of de Novo's having achieved the minimum timeline. Lets take Aug-Sep 2026 as a likely best case for approval. Then there is the need to scale up the manufacturing before meaningful distribution. So that means at least the end of 2026 - with the Gen 2 being 6-12 months behind, with its somewhat shorter 510K approval pathway.

Expand

Cheers for that. Although I have EMV on my watchlist, I haven't taken a position yet due what you have described above, and it was good to get my thoughts summarised in a well explained way, with the timelines clearly estimated. Fascinating tech that I will be closely monitoring.

EMV Price at posting: $1.99 Sentiment: None Disclosure: Not Held
2 Upvote

0 Great analysis

Reply

Top Stories

CC9

Chariot locks in high-potential drill target at Black Mountain, one of the USA's largest lithium landholdings

The Rising Tide: How institutional adoption is shaping the future of crypto

SER

How flooding did Strategic Energy Resources a favour: Four holes down in 'redesigned' gold & copper campaign

Week 34 Wrap: HotCopper's top watched; Oz banks cut saver interest; Kamala’s 28% corporate tax; AI’s back

Why are so many ASX explorers setting up shop in Saudi Arabia? + 8 stocks to watch

There are more pages in this discussion • 33 more messages in this thread...

First 14 Last

Add EMV (ASX) to my watchlist

(20min delay)
Last $2.11		Change 0.030(1.44%)		Mkt cap ! $178.5M

Open	High	Low	Value	Volume
$2.08	$2.14	$2.04	$52.92K	25.44K

Buyers (Bids)

No.	Vol.	Price($)
2	28	$2.12

Sellers (Offers)

Price($)	Vol.	No.
$2.16	1432	1

View Market Depth

No.	Vol.	Price($)
2	28	2.120
1	20	2.100
1	25	2.090
1	20	2.080
1	20	2.070

Price($)	Vol.	No.
2.160	1432	1
2.170	985	2
2.180	10000	1
2.200	21000	1
2.240	1000	1

Last trade - 14.33pm 26/08/2024 (20 minute delay)

EMV (ASX) Chart

Ann: First Responder Device Unveiled, page-14

Chariot locks in high-potential drill target at Black Mountain, one of the USA's largest lithium landholdings

The Rising Tide: How institutional adoption is shaping the future of crypto

How flooding did Strategic Energy Resources a favour: Four holes down in 'redesigned' gold & copper campaign

Week 34 Wrap: HotCopper's top watched; Oz banks cut saver interest; Kamala’s 28% corporate tax; AI’s back

Why are so many ASX explorers setting up shop in Saudi Arabia? + 8 stocks to watch

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: First Responder Device Unveiled, page-14

Top Stories

Chariot locks in high-potential drill target at Black Mountain, one of the USA's largest lithium landholdings

The Rising Tide: How institutional adoption is shaping the future of crypto

How flooding did Strategic Energy Resources a favour: Four holes down in 'redesigned' gold & copper campaign

Week 34 Wrap: HotCopper's top watched; Oz banks cut saver interest; Kamala’s 28% corporate tax; AI’s back

Why are so many ASX explorers setting up shop in Saudi Arabia? + 8 stocks to watch

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News